Ceska Televize: MLS® enters the fray for treating COVID-19 pneumonia

21 January 2021 - Therapies -

After viewing the successful results obtained by Doctor Scott Sigman (an orthopaedic surgeon in Massachusetts) when using MLS® Laser Therapy for a clinical trial to treat interstitial pneumonia caused by COVID-19, this was also adopted by the doctors in the Covid Unit of the Kolin Hospital, in Bohemia.

This was announced by Ceska Televize, the TV channel in the Czech Republic, which interviewed the chief physician of the facility:

“Following our direct experience, we confirm the value of MLS® in the treatment of interstitial pneumonia caused by the virus. Its action consists in reducing the progress of the tissue inflammation, with consequences also on pulmonary fibrotization”.

You might also be interested in ...

See all articles

M6 laser & pain management
news - 21/01/2021
“Following our direct experience, we confirm the conclusions reached in America in relation to the value of MLS® for treating interstitial pneumonia caused by the virus. Its action consists in...
COVID19 case report - laser beam positioning
blog - 02/10/2020
A new case confirms the effectiveness of MLS® as supporting therapy for treating pneumonia caused by COVID-19.
First Use of PBMT in COVID-19
Research
S.A. Sigman, S. Mokmeli, M. Monici, M. A. Vetrici American Journal of Case Reports, 21:e926779, 2020  This report has presented supportive PBMT in a patient with severe COVID-19 pneumonia....
Press - 23/01/2025
Anti-inflammatory, muscle relaxant and effective in rapidly reducing pain, MLS® Laser Therapy is the recommended therapy to successfully treat various muscular diseases.
Press - 23/01/2025
New valuable milestones for MLS® Laser Therapy, which is confirmed as a decisive therapy in pain management.
 Diabetic Peripheral Neuropathic Pain Using MiS MLS Laser
Blog - 23/01/2025
This clinical case highlights the effectiveness of using the MiS laser device on a 67-year-old woman who was diagnosed with type II diabetes mellitus in 2008.